Automated Aseptic Sampling For Accelerated Access To Process And Quality Data In Upstream Bioprocessing

By Allyson Caron

The biopharmaceutical market is experiencing a surge in demand for new medicines, cost reduction, and new product classes, which is driving the need for enhanced flexibility and cost-control measures in manufacturing. The concept of Biopharma 4.0 aims to accomplish these targets through various strategies, including the implementation of process analytical technologies (PATs) as well as the integration of digital technologies and new data management tools.

Here, we focus on PAT and the use of automated sampling technology to accelerate analytical and quality control methods. Explore the benefits of automated sampling in upstream process development as well as an approach for accessing in-line data to monitor processes in real time.